本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

432.00
-13.8500-3.11%
盘后432.000.00000.00%17:58 EST
成交量:40.76万
成交额:1.77亿
市值:99.10亿
市盈率:-33.62
高:442.50
开:441.33
低:430.01
收:445.85
52周最高:615.00
52周最低:265.00
股本:2,294.00万
流通股本:1,100.01万
量比:0.96
换手率:3.71%
股息:- -
股息率:- -
每股收益(TTM):-12.8501
每股收益(LYR):-12.8501
净资产收益率:-42.49%
总资产收益率:-16.30%
市净率:16.44
市盈率(LYR):-33.62

数据加载中...

2026/02/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]